% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Delaunay:282899,
author = {S. Delaunay$^*$ and M. Helm and M. Frye$^*$},
title = {{RNA} modifications in physiology and disease: towards
clinical applications.},
journal = {Nature reviews / Genetics},
volume = {25},
number = {2},
issn = {1471-0056},
address = {London},
publisher = {Nature Publ. Group},
reportid = {DKFZ-2023-01892},
pages = {104-122},
year = {2024},
note = {#EA:A350#LA:A350# / 2024 Feb;25(2):104-122},
abstract = {The ability of chemical modifications of single nucleotides
to alter the electrostatic charge, hydrophobic surface and
base pairing of RNA molecules is exploited for the clinical
use of stable artificial RNAs such as mRNA vaccines and
synthetic small RNA molecules - to increase or decrease the
expression of therapeutic proteins. Furthermore, naturally
occurring biochemical modifications of nucleotides regulate
RNA metabolism and function to modulate crucial cellular
processes. Studies showing the mechanisms by which RNA
modifications regulate basic cell functions in higher
organisms have led to greater understanding of how aberrant
RNA modification profiles can cause disease in humans.
Together, these basic science discoveries have unravelled
the molecular and cellular functions of RNA modifications,
have provided new prospects for therapeutic manipulation and
have led to a range of innovative clinical approaches.},
subtyp = {Review Article},
cin = {A350},
ddc = {570},
cid = {I:(DE-He78)A350-20160331},
pnm = {311 - Zellbiologie und Tumorbiologie (POF4-311)},
pid = {G:(DE-HGF)POF4-311},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37714958},
doi = {10.1038/s41576-023-00645-2},
url = {https://inrepo02.dkfz.de/record/282899},
}